A cost-effectiveness analysis of the IBD-BOOST randomized controlled trial found that a facilitator-supported digital self-management program is highly likely to…
Browsing: Clinical Updates
Experts at IDWeek 2025 emphasized that diagnosing Clostridioides difficile infection (CDI) now requires greater clinical judgment, as highly sensitive molecular…
The American College of Gastroenterology and the American Gastroenterological Association have issued statements highlighting some concerns and important factors to…
Zobair Younossi, Chairman of the Global NASH/MASH Council and Professor of Medicine at Georgetown University, reviewed the latest global consensus…
A new study published in Cell Host & Microbe suggests that removing precancerous colorectal polyps may not fully eliminate a…
Guardant Health announced that its Shield blood test for colorectal cancer (CRC) screening is now covered by UnitedHealth Group, making…
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that Signatera has received regulatory approval…
A Medscape commentary highlights a growing trend in which some patients are more hesitant about evidence-based procedures like colonoscopy while…
Experts at the 2026 Crohn’s & Colitis Congress argued that so-called “treatment-refractory” IBD is often not true drug failure, but…
Key Takeaways Automated text reminders were associated with a 9.0-percentage-point higher FIT completion rate than nurse-led telephone outreach in a…